Johnson & Johnson: heavy loss due to tax reform
(CercleFinance.com) - Johnson & Johnson has reported a Q4 2017 net loss of 10.
7 billion dollars, weighed on by heavy extraordinary charges mainly relating to the recent tax reforms in the US.
In adjusted terms, the healthcare group saw its net profit rise 9.5% to 4.8 billion dollars, or 1.74 dollars per share, which represents EPS that is two cents above the consensus. Its revenues increased by 11.5% to 20.2 billion dollars (+9.4% in operating terms).
With adjusted EPS that is up 8.5% at 7.30 dollars over the full year, which is the top of its latest target range (7.25 dollars to 7.30 dollars), Johnson & Johnson expects further growth in 2018 to between 8 dollars and 8.20 dollars.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
7 billion dollars, weighed on by heavy extraordinary charges mainly relating to the recent tax reforms in the US.
In adjusted terms, the healthcare group saw its net profit rise 9.5% to 4.8 billion dollars, or 1.74 dollars per share, which represents EPS that is two cents above the consensus. Its revenues increased by 11.5% to 20.2 billion dollars (+9.4% in operating terms).
With adjusted EPS that is up 8.5% at 7.30 dollars over the full year, which is the top of its latest target range (7.25 dollars to 7.30 dollars), Johnson & Johnson expects further growth in 2018 to between 8 dollars and 8.20 dollars.
Copyright (c) 2018 CercleFinance.com. All rights reserved.